Arcadia Biosciences, Inc. (RKDA) Gross margin 2017–2025
Arcadia Biosciences, Inc. (RKDA) gross margin by fiscal year — reported gross profit divided by reported revenue.
36.2%FY2025 · since FY2017: 93.0% → 36.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 36.2% | -5.0 pp |
| FY2024 | 41.3% | -9.9 pp |
| FY2023 | 51.2% | +33.4 pp |
| FY2022 | 17.8% | +46.2 pp |
| FY2021 | -28.4% | -63.7 pp |
| FY2020 | 35.3% | — |
| FY2017 | 93.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice